PRO DEX Inc revenue
PRO DEX Inc's revenue was $77.5m in fiscal 2026, up 16.5% on the year before. Since fiscal 2011 ($24.1m) it has grown at a compound 8.1% a year. Over the last twelve months it was $79.6m.
Revenue history
| Fiscal year | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 17 | 12 | 11 | 13 | 20 | 22 | 22 | 27 | 35 | 38 | 42 | 46 | 54 | 67 | 78 | 80 |
| Growth on the year before | — | −28.3% | −29.0% | −11.7% | +23.8% | +50.6% | +8.9% | +2.4% | +21.0% | +28.2% | +9.2% | +10.5% | +9.6% | +16.8% | +23.7% | +16.5% | — |
| Gross profit | 10 | 5 | 4 | 3 | 4 | 5 | 7 | 8 | 10 | 13 | 14 | 13 | 13 | 15 | 20 | 24 | 26 |
| Gross margin | 42.1% | 31.4% | 30.3% | 27.4% | 27.7% | 24.4% | 32.7% | 35.4% | 36.0% | 37.7% | 35.7% | 31.2% | 27.7% | 27.0% | 29.3% | 31.4% | 32.5% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| PRO DEX Inc | $79.6m | 13.3% | 19.2% |
| Tela Bio, Inc. | $79.9m | 6.1% | 17.6% |
| Sight Sciences, Inc. | $83.4m | 9.3% | 0.8% |
| Avita Medical, Inc. | $75.6m | 1.0% | 22.8% |
| Electromed, Inc. | $73.8m | 15.3% | 15.4% |
| Pulmonx Corp | $87.4m | -3.4% | 13.0% |
Compare with peers
- Tela Bio, Inc. revenue
- Sight Sciences, Inc. revenue
- Avita Medical, Inc. revenue
- Electromed, Inc. revenue
- Pulmonx Corp revenue
Head to head: PDEX vs TELAPDEX vs SGHTPDEX vs RCELELMD vs PDEX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies